Abstract:Epidemiologic studies report lower rates of cardiovascular disease in Asian populations where soy products are a staple food. Soy protein consumption has been shown to reduce non‐HDL cholesterol and is the richest dietary source of isoflavones (phytoestrogens), a group of bioactive compounds also shown to have potentially favorable effects on CVD risk. We are conducting a randomized, three‐period, double blind crossover study designed to evaluate the effects of soy protein supplementation on HDL function (measured via cholesterol efflux), central blood pressure and indices of arterial stiffness. Healthy males and females 35–60 years of age with systolic blood pressure ≥120 mm Hg and/or diastolic blood pressure ≥80 mm Hg were recruited. The three dietary treatments are: A) 25 g/d soy protein isolate (SPI); B) 50 g/d SPI; and C) 0 g/d SPI (isocaloric carbohydrate control). Participants were free living and followed their habitual diets to which they incorporated the SPI or control powders mixed with milk or water twice daily for 6 weeks each followed by a 2‐week break between treatments. Participants were instructed to keep their diet consistent during treatment periods and asked not to consume any soy containing products other than those provided. Three day dietary records were completed at baseline and during the last week of each treatment to ensure consistency in dietary intake. Participants reported to the diet center weekly to monitor body weight, review consumption logs and collect their soy (or control) powder. Twenty participants are included in the study; 18 have completed all study procedures and 2 will complete their final treatment period by December 2015. Baseline characteristics (mean ± SE) of participants (n=20; 9M & 11F) are as follows: age 51.9 ± 0.72 years, BMI 26.4 ± 0.1 kg/m 2 , systolic blood pressure 129.7 ± 1.9 mm Hg, diastolic blood pressure 82.5 ± 1.1 mm Hg, fasting glucose 88.7 ± 1.0 mg/dL, total cholesterol 197.3 ± 3.3 mg/dl, LDL‐C 120.3 ± 3.0 mg/dL and HDL‐C 55.3 ± 1.4 mg/dL. We hypothesize that consumption of soy protein (in a dose‐dependent manner) will favorably affect HDL particle size, increase HDL‐mediated ex vivo cholesterol efflux and improve central BP and arterial health in this normolipidemic, mildly hypertensive population. Support or Funding Information Sponsored by DuPont Nutrition & Health

[Serum Triacylglycerol-Lowering Effect of Soybean Beta-Conglycinin in Hyperlipidemic Women].

Serum lipid-improving effect of soyabean β-conglycinin in hyperlipidaemic menopausal women.

Eﬀ Ect of Soy Protein on Blood Lipid Concentration in China: a Randomized Controlled Trial

Combined effects of atorvastatin and soybean isoflavones on hypercholesterolemia and lipoprotein metabolism

The Effects of Coenzyme A on Serum Lipids in Patients with Hyperlipidemia: Results of A Multicenter Clinical Trial

Effect and safety of coenzyme A on hyperlipidemia

The effects of isolated soy protein, isolated soy isoflavones and soy protein containing isoflavones on serum lipids in postmenopausal women: A systematic review and meta-analysis

EFFECT OF CONSUMPTION OF VEGETABLES,FRUITS AND SOYFOODS ON SERUM LIPIDS IN HYPERLIPEMIA PATIENTS

[Effect of Soybean Protein and High Calcium Intake on the Concentration of Serum Lipids in Hypercholesterolemic Rats].

Inhibition of Soybean Isoflavone Aglycones on Lipid Peroxidation of Plasma Lipoproteins

Soy Isoflavone Supplementation and Fasting Serum Glucose and Lipid Profile among Postmenopausal Chinese Women: A Double-Blind, Randomized, Placebo-Controlled Trial

Meta-analysis of the Effects of Soy Protein Containing Isoflavones on the Lipid Profile

Selected Soybean Varieties Regulate Hepatic LDL-Cholesterol Homeostasis Depending on Their Glycinin:β-Conglycinin Ratio

Dietary β-Conglycinin Modulates Insulin Sensitivity, Body Fat Mass, and Lipid Metabolism in Obese Otsuka Long-Evans Tokushima Fatty (OLETF) Rats

Extension Region Domain of Soybean 7S Globulin Contributes to Serum Triglyceride-Lowering Effect Via Modulation of Bile Acids Homeostasis.

Isolation of soy isoflavone aglycones and inhibition on oxidation of plasma lipoproteins

Effect of soy protein and isoflavones on blood pressure and endothelial cytokines: a 6-month randomized controlled trial among postmenopausal women.

Soy fiber improves weight loss and lipid profile in overweight and obese adults: a randomized controlled trial.

Effect of soy protein and isoflavones on blood pressure and endothelial cytokines

[Effect of Soy Isoflavones on Peri-Menopausal Symptom and Estrogen].

Effects of Soy Protein on HDL‐C Function, Central Blood Pressure, and Arterial Stiffness: Study Design and Participant Characteristics